Results 181 to 190 of about 1,484,214 (321)
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
Measuring and Validating Emotional Intelligence as Performance or Self-Report [PDF]
This is a study of emotional intelligence (EI). EI was measured by performance and self-report tasks. Data were also obtained on basic values, some standard personality dimensions such as those specified in the five-factor model, social adjustment and ...
Engelberg, Elisabeth, Sjöberg, Lennart
core
Providing brief information on clinical trials in appropriate formats may improve impressions and willingness to participate among socioeconomically disadvantaged people in France. [PDF]
Metanmo S+4 more
europepmc +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source
Initial Clinical Impressions Are Absent in Around a Quarter of Adult Emergency Department Patient Consultations: Let's Get Back to Basics. [PDF]
Egerton-Warburton D+17 more
europepmc +1 more source
SOME IMPRESSIONS OF SUNGEI BULOH LEPER HOSPITAL UNDER JAPANESE OCCUPATION
Gordon A. Ryrie
openalex +1 more source
On the Duration of an Impression Caused by Pressure on the Skin [PDF]
A. Fleming
openalex +1 more source
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen+12 more
wiley +1 more source